Avalon GloboCare Corp, a leading global developer of cell-based technologies and therapeutics, announced today that Weill Cornell Medicine has selected its subsidiary Genexosome Technologies’ proprietary...
Read More »Weill Cornell medical student wins prestigious Howard Hughes Fellowship to study exosomes
Five Weill Cornell Medical College students have been named 2017 Medical Research Fellows from the Howard Hughes Medical Institute (HHMI). It’s the most HHMI fellowships awarded to Weill Cornell students since the award’s inception in 1989. The institute offers the ...
Read More »Exosomes Project Among Six Selected for Funding by the Daedalus Fund
Six Weill Cornell scientists have been selected as winners of the Daedalus Fund for Innovation, a new medical college program that helps advance promising early-stage applied and translational research that has commercial potential. Established by Weill Cornell Dean Dr. Laurie ...
Read More »Exosome proteins predict cancer’s spread
from the Cornell Chronicle By Alla Katsnelson It’s been a long-standing mystery why certain types of cancers spread to particular organs in the body. Now, investigators at Weill Cornell Medicine have discovered precisely how this happens, supporting a century-old hypothesis ...
Read More »Tests for Double-Stranded DNA Fragments in Exosomes Could Lead to Earlier, Easier Cancer Diagnoses and Targeted Treatments
DNA fragments packaged in tumor exosomes — small tumor-secreted vesicles — can be used to identify important genetic mutations in cancer, researchers at Weill Cornell have demonstrated. Because exosomes circulate in the blood, the discovery suggests that physicians could eventually ...
Read More »